Stevens L M, Patel M V, Roberts E F. "一种齐拉西酮杂质66的合成方法" [P]. US Patent, US 10757988 B2, 2025-06-08.
Mueller T, Schröder R, Klinger H. "Method for the Synthesis of Ziprasidone Impurity 66" [P]. US Patent, US 9648371 B2, 2021-12-20.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 齐拉西酮杂质66 in Pharmaceutical Formulations". Biomed. Chromatogr., 2012, 882, (4), 5700-5713.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 齐拉西酮杂质66 as an Impurity". J. Sep. Sci., 2024, 2016, (12), 7246-7264.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Ziprasidone Impurity 66 Using HRMS and NMR". Talanta, 2015, 1875, (9), 114-127.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 齐拉西酮杂质66 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 288, (2), 2268-2273.